<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940525-2-00068</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Pursuant to the National Cooperative Research and Production Act of 1993_the Inter Company Collaboration for Aids Drug Development</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Notice is hereby given that, on April 19, 1994, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> et seq. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (``the Act''), the Inter Company Collaboration for AIDS Drug Development (``the Collaboration'') has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additional activities to be undertaken by the Collaboration and changes in its membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, AJI Pharma, Inc., Teaneck, NJ has been added as a member. Eli-Lilly and Company has voluntarily withdrawn as a member of the Collaboration. The participants have agreed to coordinate a number of clinical trials of different combinations of multiple anti-viral drugs recommended by the Collaboration's Clinical Trial Subcommittee. The trials will be conducted by clinical research organizations selected by the Collaboration, pursuant to a protocol(s) approved by the Collaboration that will permit the systematic and rapid evaluation of multiple drug combinations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and the Collaboration intends to file additional written notification disclosing all changes in membership. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> On May 27, 1993, the Collaboration filed its only notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  pursuant to section 6(b) of the Act on July 6, 1993 (58 FR 36223). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Constance K. Robinson, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director of Operations Antitrust Division. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;12757 Filed 5&hyph;24&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4410&hyph;01&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            